Back to search

Netherlands· NL-87b136a17f65

Solifenacinesuccinaat/Tamsulosinehydrochloride 6 mg/0,4 mg Focus Care, tabletten met gereguleerde afgifte

A tamsulosin und solifenacin product containing solifenacinesuccinaat + tamsulosinehydrochloride, registered in Netherlands by Focus Care Pharmaceuticals B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC G04CA53

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSolifenacinesuccinaat/Tamsulosinehydr…ATCG04CA53REGISTER NO.NL-87b136a17f65PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Tamsulosin und solifenacin is registered in 9 of 19 countries.

Countries holding a registration under ATC G04CA53 (tamsulosin und solifenacin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

Tamsulosin und solifenacin · ATC G04CA53

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
SOLIFENACINESUCCINAAT + TAMSULOSINEHYDROCHLORIDE
Manufacturer
Focus Care Pharmaceuticals B.V.
Country
Netherlands (NL)
ATC code
G04CA53
ATC class
Tamsulosin und Solifenacin
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    131306

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tamsulosin und solifenacin in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tamsulosin und solifenacin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Solicomp, Solifenacin/Tamsulosin Stada
  • Belgium · Solifenacine / Tamsulosine Eurogenerics, Solifenacine/Tamsulosine
  • Bulgaria · Везира, Везомни
  • Cyprus · Nefilin
  • Czechia · Beplasot, Jomil
  • Germany · Solifenacin/Tamsulosin Heumann, Solifenacin/Tamsulosin Ratiopharm
  • Denmark · Solifenacin/Tamsulosin Adalvo, Solifenacin/Tamsulosin Newbury
  • Estonia · Solitombo
  • Spain · Blobax, Daital
  • Finland · Solifenacin/Tamsulosin Stada, Urizia
  • France · Vecalmys
  • United Kingdom (Northern Ireland) · Solifenacin Succinate/Tamsulosin Hydrochloride Altair Science, Solifenacin Succinate/Tamsulosin Hydrochloride Altair Science Limited
  • Greece · Desoltam, Nefilin
  • Croatia · Beplasot, Semquest
  • Hungary · Mingerlan, Örgunderin
  • Ireland · Solifenacin Succinate/Tamsulosin, Solifenacin Succinate/Tamsulosin Hydrochloride Clonmel
  • Iceland · Soltamcin
  • Italy · Luracin, Solifenacina E Tamsulosin Mylan
  • Lithuania · Solitombo
  • Luxembourg · Solifenacine/Tamsulosine, Solifenacine/Tamsulosine Eurogenerics
  • Malta · Jomil
  • Norway · Solifenacin/Tamsulosin Newbury, Solifenacin/Tamsulosin Stada
  • Poland · Beplasot, Mingerlan
  • Portugal · Blatan, Solifenacina + Tansulosina Generis
  • Romania · Mingerlan, Solifenacin/Tamsulosin Gemax Pharma
  • Sweden · Urizia
  • Slovenia · Semquest, Solifenacin/Tamsulozin Belupo
  • Slovakia · Jomil, Solifenacín/Tamsulozín Belupo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cf04ef39-f94b-45d9-bdbb-546b92ec6b19
GET /v1/drugs/cf04ef39-f94b-45d9-bdbb-546b92ec6b19?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet met gereguleerde afgifte",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h131306_smpc.pdf",
  "strength": null,
  "atc_label": "Tamsulosin and solifenacin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131306",
  "excipients": [
    "BUTYLHYDROXYTOLUEEN (E 321)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "MACROGOL 6000",
    "MACROGOL 8000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MALTOSE 1-WATER",
    "MANNITOL (D-) (E 421)",
    "POLYETHYLEENOXIDE",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "SOLIFENACINESUCCINAAT",
    "TAMSULOSINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131306.pdf",
  "authorised_at": "2025/07/03",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "131306",
  "additional_monitoring": "N"
}

See everything about tamsulosin und solifenacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.